
    
      The use of CNI's after kidney transplantation is associated with typical adverse effects such
      as potential contribution to progressive impairment of renal function, hypertension, and
      metabolic abnormalities. The study consists of a run-in phase (1 month),and treatment phase
      (11 months) and safety assessment phase (1 month).
    
  